Cell-based therapies for cardiac repair: a meeting report on scientific observations and European regulatory viewpoints

Author:

Schüssler-Lenz Martina12,Beuneu Claire13,Menezes-Ferreira Margarida14,Jekerle Veronika5,Bartunek Jozef6,Chamuleau Steven7,Celis Patrick15,Doevendans Pieter18,O'Donovan Maura19,Hill Jonathan10,Hystad Marit111,Jovinge Stefan12,Kyselovič Ján113,Lipnik-Stangelj Metoda114,Maciulaitis Romaldas115,Prasad Krishna1617,Samuel Anthony118,Tenhunen Olli119,Tonn Torsten20,Rosano Giuseppe1721,Zeiher Andreas22,Salmikangas Paula119

Affiliation:

1. Committee for Advanced Therapies (CAT); European Medicines Agency (EMA); Langen Germany

2. Paul-Ehrlich-Institut; Federal Institute for Vaccines and Biomedicines; Langen Germany

3. Federal Agency for Medicines and Health Products; Brussels Belgium

4. Infarmed-National Authority of Medicines and Health Products; Lisbon Portugal

5. European Medicines Agency (EMA); London UK

6. Cardiovascular Center; OLV Hospital; Aalst Belgium

7. UMC Utrecht; The Netherlands

8. European Society of Cardiology and University Medical Center Utrecht; The Netherlands

9. Health Products Regulatory Authority; Dublin Ireland

10. NHS; London UK

11. Norwegian Medicines Agency; Oslo Norway

12. The DeVos Cardiovascular Research Program; Grand Rapids MI USA

13. Department of Pharmacology and Toxicology; Comenius University; Bratislava Slovakia

14. University of Ljubljana; Faculty of Medicine; Ljubljana Slovenia

15. Institute of Physiology and Pharmacology; Lithuanian University of Health Sciences, and State Medicines Control Agency; Kaunas Lithuania

16. MHRA; London UK

17. Cardiovascular Working Party; European Medicines Agency (EMA)

18. Mater Dei Hospital; Malta

19. Finnish Medicines Agency (Fimea); Helsinki Finland

20. Dresden University; Dresden Germany

21. St George's University of London; IRCCS San Raffaele Roma

22. University of Frankfurt; Frankfurt Germany

Funder

Energy Market Authority of Singapore

CAT

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3